Skip to content

Aspects of Vulnerability of People Living with HIV in the Alpine Arc Region

Aspects of Vulnerability of People Living with HIV in the Alpine Arc Region

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04846595
Acronym
ASPEGIC
Enrollment
595
Registered
2021-04-15
Start date
2021-02-16
Completion date
2022-10-17
Last updated
2025-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Brief summary

HIV infection in France has become a chronic disease and treatment has allowed patients to increase their life expectancy. However, these promising results suffer from a very large variability within the socio-epidemiological subgroups, and life expectancy at 20 years of age is still one third lower than in the general population. Few studies of metropolitan cohorts investigated precariousness as an independent risk factor for mortality. The investigators chose to consider the vulnerability of people living with HIV (PLWHA) through the measurement of a validated French quantitative score, called EPICES (Évaluation de la précarité et des inégalités de santé dans les centres d'examens de santé , Evaluation of precariousness and health inequalities in health examination centers).

Detailed description

HIV infection in France has become a chronic disease and treatment has allowed patients to increase their life expectancy. However, these promising results suffer from a very large variability within the socio-epidemiological subgroups, and life expectancy at 20 years of age is still one third lower than in the general population. Few studies of metropolitan cohorts investigated precariousness as an independent risk factor for mortality. The investigators chose to consider the vulnerability of people living with HIV (PLWHA) through the measurement of a validated French quantitative score, called EPICES (Evaluation of precariousness and health inequalities in health examination centers). Using a self-administered questionnaire administered during an annual follow-up visit to an infectious disease specialist, the investigators seek to define in the alpine arc region in france, socio-demographic data associated with greater precariousness among PLWHA.

Interventions

Evaluate the demographic variables and medical characteristics of people living with HIV in the Alpine Arc region

Sponsors

Centre Hospitalier Annecy Genevois
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* Any person living with HIV presenting for consultation with their infectious disease referrer. * Patient followed for at least 6 months for their HIV infection * Patient with undetectable or detectable HIV viral load * Patient of legal age at the time of the study * Patient informed of the study and having expressed no objection to the collection of health data

Exclusion criteria

* Patient opposed or unable to express opposition to participation in the study * Patient is a minor at the time of the study * Patient taking antiretroviral therapy for less than 6 months

Design outcomes

Primary

MeasureTime frameDescription
Variables of vulnerabilityone dayEvaluation of the variables associated with a state of vulnerability according to the EPICES scale (at a threshold of 30.17/100), among the social, demographic and medical characteristics of people living with HIV in the Alpine Arc region characteristics of people living with HIV in the Alpine Arc region

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026